Cargando…

The Physician Global Assessment and Body Surface Area composite tool is a simple alternative to the Psoriasis Area and Severity Index for assessment of psoriasis: post hoc analysis from PRISTINE and PRESTA

BACKGROUND: The product of Physician Global Assessment and Body Surface Area (PGA × BSA) is a new outcome measure for psoriasis severity and response to therapy. The objective of this study was to evaluate PGA × BSA as an alternative to Psoriasis Area and Severity Index (PASI) for psoriasis assessme...

Descripción completa

Detalles Bibliográficos
Autores principales:	Walsh, Jessica A, Jones, Heather, Mallbris, Lotus, Duffin, Kristina Callis, Krueger, Gerald G, Clegg, Daniel O, Szumski, Annette
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6181091/ https://www.ncbi.nlm.nih.gov/pubmed/30324088 http://dx.doi.org/10.2147/PTT.S169333

Ejemplares similares

A multi-item Physician Global Assessment scale to assess psoriasis disease severity: validation based on four phase III tofacitinib studies
por: Callis Duffin, Kristina, et al.
Publicado: (2019)

Psoriasis Severity Assessment Combining Physician and Patient Reported Outcomes: The Optimal Psoriasis Assessment Tool
por: Leonardi, Craig, et al.
Publicado: (2021)

Risk of respiratory infection in patients with plaque psoriasis
por: Svedbom, Axel, et al.
Publicado: (2021)

Ustekinumab-induced remission of recalcitrant guttate psoriasis: A case series
por: Brummer, Grace C., et al.
Publicado: (2017)

The 5q31 variants associated with psoriasis and Crohn's disease are distinct
por: Li, Yonghong, et al.
Publicado: (2008)

Translation and Validation of the Self-Assessment Psoriasis Area Severity Index
por: Laskowski, Marta, et al.
Publicado: (2023)

HLA-Cw*0602 associates with a twofold higher prevalence of positive streptococcal throat swab at the onset of psoriasis: a case control study
por: Mallbris, Lotus, et al.
Publicado: (2009)

Demographics, Disease Characteristics, and Patient-Reported Outcomes Among Patients with Psoriasis Who Initiated Guselkumab in CorEvitas’ Psoriasis Registry
por: Walsh, Jessica A., et al.
Publicado: (2021)

Effectiveness of Guselkumab Therapy among Patients with Plaque Psoriasis with Baseline IGA Score ≥ 2 in the CorEvitas Psoriasis Registry
por: Armstrong, April W., et al.
Publicado: (2022)

Employment is maintained and sick days decreased in psoriasis/psoriatic arthritis patients with etanercept treatment
por: Boggs, Robert L, et al.
Publicado: (2014)

Evidence and Suggested Therapeutic Approach in Psoriasis of Difficult-to-treat Areas: Palmoplantar Psoriasis, Nail Psoriasis, Scalp Psoriasis, and Intertriginous Psoriasis
por: Sarma, Nilendu
Publicado: (2017)

Effect of etanercept therapy on psoriasis symptoms in patients from Latin America, Central Europe, and Asia: a subset analysis of the PRISTINE trial
por: Kemeny, L., et al.
Publicado: (2015)

Real-World Effectiveness of 9–12 Months of Guselkumab Therapy among Patients with Moderate-to-Severe Plaque Psoriasis in the CorEvitas Psoriasis Registry
por: Armstrong, April W., et al.
Publicado: (2022)

Genetic signature to provide robust risk assessment of psoriatic arthritis development in psoriasis patients
por: Patrick, Matthew T., et al.
Publicado: (2018)

Is Clear Always Clear? Comparison of Psoriasis Area and Severity Index (PASI) and the Physician’s Global Assessment (PGA) in Psoriasis Clearance
por: Wu, Albert G., et al.
Publicado: (2020)

Multiple Loci within the Major Histocompatibility Complex Confer Risk of Psoriasis
por: Feng, Bing-Jian, et al.
Publicado: (2009)

Number Needed to Treat Network Meta-Analysis to Compare Biologic Drugs for Moderate-to-Severe Psoriasis
por: Leonardi, Craig L., et al.
Publicado: (2022)

The Proposed PASI-HD Provides More Precise Assessment of Plaque Psoriasis Severity in Anatomical Regions with a Low Area Score
por: Papp, Kim A., et al.
Publicado: (2021)

Feasibility and Utility of the Psoriasis Symptom Inventory (PSI) in Clinical Care Settings: A Study from the International Psoriasis Council
por: Strober, Bruce, et al.
Publicado: (2019)

PrestaShop module development: develop and customize powerful modules for PrestaShop 1.5 and 1.6
por: Serny, Fabien, et al.
Publicado: (2014)

Phase 3, open‐label, randomized study of the pharmacokinetics, efficacy and safety of ixekizumab following subcutaneous administration using a prefilled syringe or an autoinjector in patients with moderate‐to‐severe plaque psoriasis (UNCOVER‐A)
por: Callis Duffin, K., et al.
Publicado: (2016)

The Association between Psoriasis Area and Severity Index and Cardiovascular Risk Factor in Korean Psoriasis Patients
por: Ku, Sang Hyeon, et al.
Publicado: (2016)

Correlation of Psoriasis Disability Index and Psoriasis Area and Severity Index: A Study from Afghanistan
por: Aalemi, Ahmad Khalid, et al.
Publicado: (2022)

Disease Assessment in Psoriasis
por: Manchanda, Yashpal, et al.
Publicado: (2023)

Reduction of Inter-Rater and Intra-Rater Variability in Psoriasis Area and Severity Index Assessment by Photographic Training
por: Youn, Sang Woong, et al.
Publicado: (2015)

PrestaShop recipes: a problem-solution approach
por: Pérez Castaño, Arnaldo
Publicado: (2017)

PRESTA: associating promoter sequences with information on gene expression
por: Mach, Václav
Publicado: (2002)

Long‐term, durable, absolute Psoriasis Area and Severity Index and health‐related quality of life improvements with risankizumab treatment: a post hoc integrated analysis of patients with moderate‐to‐severe plaque psoriasis
por: Gooderham, M., et al.
Publicado: (2022)

The correlation between the psoriasis area severity index and ischemia-modified albumin, mean platelet volume levels in patients with psoriasis
por: Işik, Selda, et al.
Publicado: (2016)

Underdiagnosed and undertreated psoriasis: Nuances of treating psoriasis affecting the scalp, face, intertriginous areas, genitals, hands, feet, and nails
por: Merola, Joseph F., et al.
Publicado: (2018)

Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA): updated treatment recommendations for psoriatic arthritis 2021
por: Coates, Laura C., et al.
Publicado: (2022)

Measurement of Body Surface Area for Psoriasis Using U-net Models
por: Lin, Yih-Lon, et al.
Publicado: (2022)

An Assessment of the Cost-Utility of Therapy for Psoriasis
por: Weiss, Stefan C, et al.
Publicado: (2006)

Echocardiographic and electrocardiographic assessments in patients with psoriasis
por: Aryanian, Zeinab, et al.
Publicado: (2021)

Efficacy of ixekizumab on nail psoriasis in paediatric patients with moderate‐to‐severe psoriasis: a post hoc analysis from IXORA‐PEDS
por: Seyger, M.M.B., et al.
Publicado: (2021)

Bounded integer model‐based analysis of psoriasis area and severity index in patients with moderate‐to‐severe plaque psoriasis receiving BI 730357
por: Ooi, Qing Xi, et al.
Publicado: (2023)

The Relationship between Tissue Thioredoxin Reductase Activity and the Psoriasis Area and Severity Index
por: Kiafar, Bita, et al.
Publicado: (2020)

Psoriasis Management Challenges Regarding Difficult-to-Treat Areas: Therapeutic Decision and Effectiveness
por: Nicolescu, Alin Codrut, et al.
Publicado: (2022)

Development and Content Validation of the Psoriasis Symptoms and Impacts Measure (P-SIM) for Assessment of Plaque Psoriasis
por: Gottlieb, Alice B., et al.
Publicado: (2020)

Pregnancy Outcomes in Women With Moderate-to-Severe Psoriasis From the Psoriasis Longitudinal Assessment and Registry (PSOLAR)
por: Kimball, Alexa B., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_0hvrmssj659bn8qs01pv6e10ed